Symbols / BEAT $1.22 +8.93% HeartBeam, Inc.

Healthcare • Health Information Services • United States • NCM
BEAT Chart
About

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Health Information Servi Market Cap 50.13M
Enterprise Value 45.75M Income -21.02M Sales —
Book/sh 0.07 Cash/sh 0.11 Dividend Yield —
Payout 0.00% Employees 16 IPO —
P/E — Forward P/E -2.30 PEG —
P/S — P/B 18.77 P/C —
EV/EBITDA -2.17 EV/Sales — Quick Ratio 1.35
Current Ratio 1.45 Debt/Eq — LT Debt/Eq —
EPS (ttm) -0.62 EPS next Y -0.53 EPS Growth —
Revenue Growth — Earnings 2026-05-15 ROA -289.77%
ROE -9.87% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 41.09M
Shs Float 33.90M Short Float 11.34% Short Ratio 1.69
Short Interest — 52W High 4.00 52W Low 0.54
Beta -0.80 Avg Volume 1.37M Volume 473.19K
Target Price $5.30 Recom Strong_buy Prev Close $1.12
Price $1.22 Change 8.93%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$5.30
Mean price target
2. Current target
$1.22
Latest analyst target
3. DCF / Fair value
$-3.03
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.22
Low
$4.00
High
$8.00
Mean
$5.30

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-31 init B. Riley Securities — → Buy $4
2026-03-30 main D. Boral Capital Buy → Buy $5
2026-03-27 init D. Boral Capital — → Buy $5
2026-03-16 reit HC Wainwright & Co. Buy → Buy $6
2025-12-11 up Benchmark Speculative Buy → Buy $8
2025-12-10 main HC Wainwright & Co. Buy → Buy $6
2025-12-08 init HC Wainwright & Co. — → Buy $3
2024-11-15 reit Benchmark Speculative Buy → Speculative Buy $8
2024-05-13 reit Benchmark Speculative Buy → Speculative Buy $8
2024-03-25 reit Benchmark Speculative Buy → Speculative Buy $8
2023-11-16 reit Benchmark Speculative Buy → Speculative Buy $8
2023-08-24 reit Benchmark Speculative Buy → Speculative Buy $8
2023-05-19 main Alliance Global Partners Buy → Buy $6
2023-05-19 reit Benchmark Speculative Buy → Speculative Buy $8
2023-03-21 reit Benchmark — → Speculative Buy $8
2022-12-02 init Alliance Global Partners — → Buy $10
2021-12-20 init Benchmark — → Speculative Buy $9
News
RSS: Latest BEAT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-09 FERRARI RICHARD M Director — 50,000 $0.00 $0
2026-02-09 NELSON KENNETH WARWICK III Director — 17,241 $0.00 $0
2026-02-09 JAFF MICHAEL R. Director — 20,689 $0.00 $0
2025-12-18 DE URIOSTE GEORGE A. Director — 57,146 $2.83 $182,090
2025-12-17 STROME MARK E. Beneficial Owner of more than 10% of a Class of Security — 250,000 $3.58 $895,000
2025-02-14 FERRARI RICHARD M Director — 29,412 $2.13 $62,648
2025-02-14 CRUICKSHANK TIMOTHY Chief Financial Officer — 17,647 $2.13 $37,588
2024-09-06 DE URIOSTE GEORGE A. Director — 1,674 $2.34 $3,917
2024-08-30 DE URIOSTE GEORGE A. Director — 5,500 $2.31 $12,705
2024-08-27 DE URIOSTE GEORGE A. Director — 2,194 $2.26 $4,958
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
21.14
+6.30%
19.89
+29.86%
15.31
+17.52%
13.03
Research And Development
13.45
+21.71%
11.05
+62.56%
6.80
+19.75%
5.68
Selling General And Administration
7.69
-12.98%
8.84
+3.76%
8.52
+15.80%
7.35
General And Administrative Expense
7.69
-12.98%
8.84
+3.76%
8.52
+15.80%
7.35
Other Gand A
7.69
-12.98%
8.84
+3.76%
8.52
+15.80%
7.35
Total Expenses
21.14
+6.30%
19.89
+29.86%
15.31
+17.52%
13.03
Operating Income
-21.14
-6.30%
-19.89
-29.86%
-15.31
-17.52%
-13.03
Total Operating Income As Reported
-21.14
-6.30%
-19.89
-29.86%
-15.31
-17.52%
-13.03
EBITDA
-21.10
-6.13%
-19.88
-29.82%
-15.31
-17.52%
-13.03
Normalized EBITDA
-21.10
-6.13%
-19.88
-29.82%
-15.31
-17.52%
-13.03
Reconciled Depreciation
0.04
+471.43%
0.01
0.00
—
EBIT
-21.14
-6.30%
-19.89
-29.86%
-15.31
-17.52%
-13.03
Net Income
-21.02
-8.06%
-19.45
-32.85%
-14.64
-12.94%
-12.96
Pretax Income
-21.02
-8.06%
-19.45
-32.85%
-14.64
-12.94%
-12.96
Net Non Operating Interest Income Expense
0.12
-72.65%
0.45
-33.93%
0.68
+922.73%
0.07
Interest Expense Non Operating
—
—
—
—
Net Interest Income
0.12
-72.65%
0.45
-33.93%
0.68
+922.73%
0.07
Interest Expense
—
—
—
—
Interest Income Non Operating
0.12
-72.65%
0.45
-33.93%
0.68
+922.73%
0.07
Interest Income
0.12
-72.65%
0.45
-33.93%
0.68
+922.73%
0.07
Other Income Expense
0.00
+128.57%
-0.01
—
0.00
Other Non Operating Income Expenses
0.00
+128.57%
-0.01
—
0.00
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-21.02
-8.06%
-19.45
-32.85%
-14.64
-12.94%
-12.96
Net Income From Continuing Operation Net Minority Interest
-21.02
-8.06%
-19.45
-32.85%
-14.64
-12.94%
-12.96
Net Income From Continuing And Discontinued Operation
-21.02
-8.06%
-19.45
-32.85%
-14.64
-12.94%
-12.96
Net Income Continuous Operations
-21.02
-8.06%
-19.45
-32.85%
-14.64
-12.94%
-12.96
Normalized Income
-21.02
-8.06%
-19.45
-32.85%
-14.64
-12.94%
-12.96
Net Income Common Stockholders
-21.02
-8.06%
-19.45
-32.85%
-14.64
-12.94%
-12.96
Diluted EPS
—
-0.73
-1.39%
-0.72
+54.72%
-1.59
Basic EPS
—
-0.73
-1.39%
-0.72
+54.72%
-1.59
Basic Average Shares
—
26.65
+31.04%
20.33
+148.92%
8.17
Diluted Average Shares
—
26.65
+31.04%
20.33
+148.92%
8.17
Diluted NI Availto Com Stockholders
-21.02
-8.06%
-19.45
-32.85%
-14.64
-12.94%
-12.96
Total Other Finance Cost
—
—
—
-0.07
Line Item Trend 2023-12-31
Total Assets
17.13
Current Assets
16.82
Cash Cash Equivalents And Short Term Investments
16.19
Cash And Cash Equivalents
16.19
Cash Financial
—
Inventory
—
Prepaid Assets
—
Other Current Assets
0.64
Total Non Current Assets
0.31
Net PPE
0.26
Other Non Current Assets
0.05
Total Liabilities Net Minority Interest
1.19
Current Liabilities
1.19
Payables And Accrued Expenses
1.19
Payables
0.56
Accounts Payable
0.56
Current Accrued Expenses
0.64
Total Non Current Liabilities Net Minority Interest
0.00
Stockholders Equity
15.94
Common Stock Equity
15.94
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
26.33
Ordinary Shares Number
26.33
Treasury Shares Number
0.00
Additional Paid In Capital
52.76
Retained Earnings
-36.83
Total Equity Gross Minority Interest
15.94
Total Capitalization
15.94
Working Capital
15.63
Invested Capital
15.94
Net Tangible Assets
15.94
Tangible Book Value
15.94
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-13.99
+3.34%
-14.47
-19.66%
-12.09
-21.56%
-9.95
Cash Flow From Continuing Operating Activities
-13.99
+3.34%
-14.47
-19.66%
-12.09
-21.56%
-9.95
Net Income From Continuing Operations
-21.02
-8.06%
-19.45
-32.85%
-14.64
-12.94%
-12.96
Depreciation Amortization Depletion
0.04
+471.43%
0.01
0.00
—
Depreciation
0.04
+471.43%
0.01
0.00
—
Depreciation And Amortization
0.04
+471.43%
0.01
0.00
—
Other Non Cash Items
0.23
—
—
—
Stock Based Compensation
5.15
+19.73%
4.30
+34.01%
3.21
+186.43%
1.12
Operating Gains Losses
—
—
—
—
Change In Working Capital
1.61
+140.54%
0.67
+201.36%
-0.66
-134.95%
1.89
Change In Inventory
-0.10
—
—
—
Change In Prepaid Assets
0.19
-21.40%
0.24
+227.23%
-0.19
-152.91%
0.36
Change In Payables And Accrued Expense
1.53
+256.54%
0.43
+190.87%
-0.47
-130.72%
1.53
Change In Payable
1.53
+256.54%
0.43
+190.87%
-0.47
-130.72%
1.53
Change In Account Payable
1.53
+256.54%
0.43
+190.87%
-0.47
-130.72%
1.53
Investing Cash Flow
-0.60
-198.51%
-0.20
+21.48%
-0.26
0.00
Cash Flow From Continuing Investing Activities
-0.60
-198.51%
-0.20
+21.48%
-0.26
0.00
Net PPE Purchase And Sale
-0.60
-198.51%
-0.20
+21.48%
-0.26
0.00
Purchase Of PPE
-0.60
-198.51%
-0.20
+21.48%
-0.26
0.00
Capital Expenditure
-0.60
-198.51%
-0.20
+21.48%
-0.26
—
Net Investment Purchase And Sale
0.00
—
—
—
Purchase Of Investment
-3.76
—
—
—
Sale Of Investment
3.76
—
—
—
Financing Cash Flow
16.59
+1815.82%
0.87
-96.54%
24.99
+7041.14%
0.35
Cash Flow From Continuing Financing Activities
16.59
+1815.82%
0.87
-96.54%
24.99
+7041.14%
0.35
Net Issuance Payments Of Debt
—
—
—
0.00
Issuance Of Debt
—
—
—
0.00
Repayment Of Debt
—
—
—
0.00
Long Term Debt Issuance
—
—
—
0.00
Net Long Term Debt Issuance
—
—
—
0.00
Short Term Debt Payments
—
—
—
0.00
Net Short Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
16.58
+2170.96%
0.73
-97.05%
24.76
+7016.09%
0.35
Proceeds From Stock Option Exercised
0.01
-90.44%
0.14
-40.87%
0.23
+11400.00%
0.00
Changes In Cash
2.00
+114.51%
-13.81
-209.18%
12.64
+231.75%
-9.60
Beginning Cash Position
2.43
-85.02%
16.24
+351.84%
3.59
-72.76%
13.19
End Cash Position
4.44
+82.33%
2.43
-85.02%
16.24
+351.84%
3.59
Free Cash Flow
-14.59
+0.57%
-14.67
-18.81%
-12.35
-24.14%
-9.95
Interest Paid Supplemental Data
—
—
0.00
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Common Stock Issuance
16.58
+2170.96%
0.73
-97.05%
24.76
+7016.09%
0.35
Issuance Of Capital Stock
16.58
+2170.96%
0.73
-97.05%
24.76
+7016.09%
0.35
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category